What chronic fatigue syndrome actually is
Myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) is defined clinically by three properties: a persistent, paralysing fatigue that does not improve with rest, cognitive impairment that patients describe as "brain fog", and post-exertional malaise — the characteristic worsening of all symptoms after exertion.
What is missing from the conventional definition is the biology. Chronic fatigue syndrome is not a psychological condition and not the result of deconditioning. It is a measurable disruption in cellular energy production — specifically in the mitochondria's ability to convert substrates to ATP via oxidative phosphorylation.
Research from the Workwell Foundation, Stanford ME/CFS Initiative and Newcastle University consistently shows that ME/CFS patients have measurably impaired mitochondrial function, abnormal metabolite profiles and dysregulated immune responses. This is not a diffuse syndrome — it is a biological condition with specific mechanisms.
Post-exertional malaise — the biological mechanism
Post-exertional malaise (PEM) is ME/CFS's clinical hallmark and its most misunderstood symptom. It is not feeling somewhat more tired the day after exercise. It is a biological cascade that begins 12–72 hours after exertion and can persist for days to weeks.
The mechanism is mitochondrial. In healthy cells, ATP stores are replenished rapidly via oxidative phosphorylation in the mitochondrial inner membrane. In ME/CFS this process is dysfunctional — cells cannot meet energy demand and fall back on anaerobic glycolysis, which produces 94% less ATP and generates lactate as a byproduct.
The immune system activates in parallel. Cytokines (IL-6, TNF-α) rise, neuroinflammation increases and the autonomic nervous system dysregulates. The result is a crash period that is impossible to overcome with willpower or exercise — and which worsens with the attempt.
Pacing is not giving up. It is the only rational treatment strategy until the biological constraint has been identified and addressed.
The primary biological constraints
Based on clinical experience and published research, there is a hierarchy of biological factors driving mitochondrial dysfunction in chronic fatigue syndrome:
- Intracellular CoQ10 deficiency — CoQ10 (ubiquinone) is critical for the electron transport chain in the mitochondria. Deficiency means ATP synthesis is structurally impaired regardless of substrate availability. Serum levels do not reflect intracellular status. CMA analysis is the only way to verify the intracellular level.
- L-carnitine deficiency — L-carnitine transports long-chain fatty acids into mitochondria for beta-oxidation. Deficiency blocks one of the mitochondria's primary fuels. Verified via NutrEval®.
- NAD+ depletion — NAD+ is a cofactor in the citric acid cycle and for sirtuins (mitochondrial repair genes). NAD+ levels decline with age, oxidative stress and chronic illness. Measured via organic acids in the NutrEval® panel.
- Chronic HPA axis dysregulation — Cortisol regulates mitochondrial biogenesis. Dysregulated cortisol from chronic stress and sleep disturbance progressively damages mitochondrial function. Documented via Adrenal Stress Profile.
- Gut dysbiosis and intestinal permeability — The gut-brain axis directly influences mitochondrial function via butyrate (primary fuel for colonocytes and important for mitochondrial ATP synthesis). Leaky gut generates systemic endotoxin load (LPS) that inhibits mitochondrial complex I. Measured via GI Effects®.
- Oxidative stress — Chronic oxidative stress damages mitochondrial membranes, lipids and DNA. Revealed via 8-OHdG and lipid peroxidation markers in the NutrEval® Oxidative Stress panel.
In our patient cohort with verified ME/CFS and chronic fatigue, the three most common combination findings are: intracellular CoQ10 deficiency + elevated morning cortisol with low evening cortisol + elevated intestinal permeability (zonulin). None of these are identified by standard blood tests. All three are reversible with targeted intervention — but not without having measured them.
Why standard blood tests miss this
Standard blood tests measure serum levels — the concentration of substances in the blood. Mitochondrial function is an intracellular phenomenon. There is no formula that converts serum CoQ10 to mitochondrial CoQ10 in heart muscle. Serum magnesium stays normal until the body is severely depleted. Organic acids — the metabolites that reveal bottlenecks in the citric acid cycle — are not measured at all in standard chemistry panels.
The consequence is that ME/CFS patients consistently show normal standard tests and therefore receive no biological explanation for their symptoms. This is not a diagnostic failure on the part of the patient — it is a structural limitation in what standard blood tests are designed to answer.
Investigation protocol at MediBalans
A complete fatigue investigation requires analysis at five biological levels:
- Intracellular nutrition — CMA measures 35 micronutrients in white blood cells, including CoQ10, L-carnitine, magnesium, B vitamins and antioxidants
- Metabolomics — NutrEval® measures organic acids, fatty acids and amino acid metabolites revealing where in the energy metabolism the bottlenecks sit
- HPA axis status — Adrenal Stress Profile (DUTCH or salivary cortisol) measures the cortisol diurnal curve and DHEA-S ratio
- Gut status — GI Effects® reveals dysbiosis, intestinal permeability and inflammatory markers; alternatively zonulin separately
- Autonomic nervous system — HRV analysis provides an integrated measure of biological stress load
If you have chronic fatigue and your blood tests show "everything normal" — it probably doesn't mean nothing is wrong. It means standard blood tests are not measuring what is actually wrong.
Mitochondrial dysfunction does not appear in a standard B12 or ferritin analysis. It appears in intracellular measurements of CoQ10, carnitine and organic acids — measurements that never appear in routine investigations.
What we measure is the cells' actual nutritional status and energy production capacity. Then we treat the specific finding with the right form, the right dose and the right treatment sequence. Without testing, supplementation is guesswork.